Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients

Anti-IL6R therapy appears effective in reducing disease activity in both NMOSD and MOGAD, particularly in patients previously unresponsive to rituximab.

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis Journal
Published
2025-12-17
DOI
https://doi.org/10.1177/13524585251396421
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients

Romain Deschamps, Xavier Ayrignac, Jonathan Ciron, Caroline Papeix et al.
Multiple Sclerosis Journal
Inflammasome and immune disorders
article

Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients

Romain Deschamps, Xavier Ayrignac, Jonathan Ciron, Caroline Papeix, Bertrand Bourre, Élisabeth Maillart, Aurélie Ruet, Mikaël Cohen, Hélène Zéphir, Éric Thouvenot, Nicolas Collongues, Laure Michel, Bertrand Audoin, Guillaume Jouvenot, Françoise Durand‐Dubief, Romain Marignier, Chloé Comet
article en

Abstract

Anti-IL6R therapy appears effective in reducing disease activity in both NMOSD and MOGAD, particularly in patients previously unresponsive to rituximab.

Multiple Sclerosis JournalVol. 32(2)
Inserm (FR), Aix-Marseille Université (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Centre Hospitalier Universitaire de Toulouse (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Montpellier (FR), Observatoire Français de la Sclérose en Plaques (FR), Hôpital Pierre Wertheimer (FR), Hôpital Pellegrin (FR), Pitié-Salpêtrière Hospital (FR), Fondation Ophtalmologique Adolphe de Rothschild (FR), Fondation de Rothschild (FR), Lille Inflammation Research International Center (FR), Hôpital Pasteur (FR), Centre Hospitalier Universitaire de Rouen (FR), Centre Hospitalier Universitaire de Rennes (FR), Institut de Génomique Fonctionnelle (FR), Université de Strasbourg (FR)
Openalex Percentile: Top 63%
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.